Skip to main content
The Journal of Nutrition logoLink to The Journal of Nutrition
. 2014 Oct 8;144(12):2018–2026. doi: 10.3945/jn.114.198341

Food Intake Does Not Differ between Obese Women Who Are Metabolically Healthy or Abnormal1,2,3,4

Ruth W Kimokoti 5,*, Suzanne E Judd 6, James M Shikany 7, PK Newby 8,9
PMCID: PMC4230212  PMID: 25411036

Abstract

Background: Metabolically healthy obesity may confer lower risk of adverse health outcomes compared with abnormal obesity. Diet and race are postulated to influence the phenotype, but their roles and their interrelations on healthy obesity are unclear.

Objective: We evaluated food intakes of metabolically healthy obese women in comparison to intakes of their metabolically healthy normal-weight and metabolically abnormal obese counterparts.

Methods: This was a cross-sectional study in 6964 women of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Participants were aged 45–98 y with a body mass index (BMI; kg/m2) ≥18.5 and free of cardiovascular diseases, diabetes, and cancer. Food intake was collected by using a food-frequency questionnaire. BMI phenotypes were defined by using metabolic syndrome (MetS) and homeostasis model assessment of insulin resistance (HOMA-IR) criteria. Mean differences in food intakes among BMI phenotypes were compared by using ANCOVA.

Results: Approximately one-half of obese women (white: 45%; black: 55%) as defined by MetS criteria and approximately one-quarter of obese women (white: 28%; black: 24%) defined on the basis of HOMA-IR values were metabolically healthy. In age-adjusted analyses, healthy obesity and normal weight as defined by both criteria were associated with lower intakes of sugar-sweetened beverages compared with abnormal obesity among both white and black women (P < 0.05). HOMA-IR–defined healthy obesity and normal weight were also associated with higher fruit and low-fat dairy intakes compared with abnormal obesity in white women (P < 0.05). Results were attenuated and became nonsignificant in multivariable-adjusted models that additionally adjusted for BMI, marital status, residential region, education, annual income, alcohol intake, multivitamin use, cigarette smoking status, physical activity, television viewing, high-sensitivity C-reactive protein, menopausal status, hormone therapy, and food intakes.

Conclusions: Healthy obesity was not associated with a healthier diet. Prospective studies on relations of dietary patterns, which may be a better indicator of usual diet, with the phenotype would be beneficial.

Keywords: diet, healthy, metabolic, obesity, phenotype

Introduction

Obesity is associated with a high risk of cardiovascular diseases (CVDs)10, type 2 diabetes, certain forms of cancer, other metabolic disorders, and mortality (15). Obesity, however, shows considerable heterogeneity; compared with abnormal obesity, healthy obesity is characterized by a favorable metabolic profile and may confer lower risk of adverse health outcomes (612). Currently, there is no standardized definition of healthy obesity and the phenotype has been defined by using criteria for metabolic syndrome (MetS) (715), a cluster of cardiometabolic risk factors (16), and/or insulin sensitivity/resistance measures (7, 8, 1013, 17, 18). Approximately one-third of women in the United States are obese (19), and an approximately equal proportion of these are metabolically healthy (13).

The etiology of healthy obesity is unclear, but genetic and lifestyle factors, sex, and race may influence the phenotype (6, 7). A few studies evaluated dietary intake of healthy obese individuals (2022). Among U.S. participants of the INTERMAP (International Population Study on Macro/Micronutrients and Blood Pressure), nutrient and food intakes of healthy and unhealthy obese individuals were similar (20). Likewise, energy, carbohydrate, fat, and protein intakes did not differ between obese phenotypes in the third Korean NHANES (21). Conversely, healthy obese women who participated in the 1999–2004 U.S. NHANES had lower fiber intake and higher alcohol consumption than did their normal-weight counterparts (22). Moreover, it is established that obesity epidemiology, body composition, and fat distribution as well as energy, glucose and lipid metabolism, and insulin homeostasis differ by sex and race (2326). Sex and race also influence dietary intake and dietary patterns due in part to gender-influenced eating behaviors, cultural differences, and socioeconomic status (2, 2730; SE Judd, AJ Letter, JM Shikany, DL Roth, PK Newby, unpublished results, 2012). To our knowledge, no studies have compared food intakes of healthy obese individuals with those of their abnormal obese counterparts and other BMI phenotypes across race. Although MetS-based and HOMA-IR–defined healthy obesity have been shown to be associated with similar risks of CVDs, diabetes, and mortality (8, 10, 12), it is not known if dietary intakes of the phenotype on the basis of both criteria are similar.

In our study, we examined food intakes of metabolically healthy obese women defined by using both MetS and HOMA-IR criteria in comparison to intakes of other BMI phenotypes in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. We hypothesized that healthy obesity is associated with higher intakes of healthy foods (e.g., vegetables, fish, low-fat dairy foods) and lower consumption of less healthy foods [e.g., refined grains, processed meat, sugar-sweetened beverages (SSBs)] than abnormal obesity but with food intakes similar to the healthy normal-weight phenotype.

Methods

Study population

The REGARDS study is a national prospective cohort study that was designed to examine geographic and racial variations in stroke and its risk factors. The design and methods of the study are described elsewhere (31). Briefly, between 2003 and 2007, 30,239 white (58%) and black (42%) adults aged ≥45 y were enrolled via mail and telephone by using commercially available lists of residents. The cohort oversampled individuals from the Stroke Belt (noncoastal regions of North Carolina, South Carolina, and Georgia as well as Alabama, Arkansas, Georgia, Louisiana, Mississippi, and Tennessee) (35%) and the Stroke Buckle (coastal plains of North Carolina, South Carolina, and Georgia) (21%); the rest (44%) were recruited from the other 40 contiguous states. The Institutional Review Board for Human Use at the University of Alabama at Birmingham approved the study protocol, and all participants provided written informed consent.

This study included 13,433 women aged 45–98 y who completed an FFQ at the baseline examination (81% of women in the main study; n = 16,632). After excluding those with >15% missing responses (n = 988) and implausible energy intakes [<500 kcal/d or >4503 kcal/d (<2093 kJ/d or >18,841 kJ/d); n = 355], a total of 12,090 women remained. Of these, 6964 (58%) had a BMI (kg/m2) ≥18.5, were free of CVDs, diabetes mellitus, and cancer and had data on covariates and cardiometabolic risk factors.

Exposure and covariate

Upon enrollment (2003–2007), individuals underwent a computer-assisted telephone interview (CATI) followed by an in-home examination. Additional information was obtained via self-administered mail-in questionnaires (31). Age, marital status, residential region, education, income, multivitamin use, alcohol intake, smoking status, physical activity, television viewing, hormone therapy, menopausal status, as well as medical information were obtained via CATI and mail-in questionnaire (31). An inventory of current medications, anthropometric and blood pressure measurements, and phlebotomy were performed during the in-home examination. Participants, dressed in hospital gowns and without shoes, were weighed with the use of a calibrated digital scale (Salter; Salter Brecknell) and height was measured by using a metal tape. BMI [weight (kg)/height (m2)] was calculated from measured height and weight. Waist circumference (WC) was measured on standing participants by using a cloth tape measure midway between the lowest rib on the right side and the top of the iliac crest (32). Blood pressure was determined by using the average of duplicate measurements with the use of an aneroid sphygmomanometer with the participant in a sitting position (31, 32). Fasting serum glucose, HDL cholesterol, and TGs were assessed by calorimetric reflectance spectrophotometry by using the Ortho Vitros Clinical Chemistry System 9501RC instrument (Johnson & Johnson Clinical Diagnostics). Serum insulin was measured by electrochemiluminescence immunoassay by using the Roche Elecsys 2010 system (Roche Diagnostics). Serum high-sensitivity C-reactive protein (hs-CRP) was analyzed by particle-enhanced immunonephelometry by using the BNII nephelometer (N High Sensitivity CRP; Dade Behring) (33).

Definition of BMI phenotypes

BMI categories were determined on the basis of NIH criteria (normal weight: 18.5 to <25.0; overweight: 25 to <30; obese: ≥30) (4). Metabolic status was defined according to both the American Heart Association/National Heart, Lung, and Blood Institute guidelines as outlined in the harmonized Joint Scientific Statement criteria for MetS (16) and HOMA-IR criteria (17, 18). MetS is defined as having ≥3 of the following individual components: abdominal obesity (WC ≥88 cm), elevated blood pressure (≥130/≥85 mm Hg) or drug therapy for hypertension, elevated glucose (≥5.6 mmol/L) or drug therapy for hyperglycemia, low HDL cholesterol (<1.3 mmol/L) or drug therapy for reduced HDL cholesterol, and elevated TGs (≥1.7 mmol/L) or drug therapy for hypertriglyceridemia (16). Insulin resistance was assessed from fasting glucose and insulin concentrations by using the formula HOMA-IR = fasting glucose (mmol/L) × fasting insulin (pmol/L)/22.5 and was defined as the highest quartile of HOMA-IR scores (17, 18).

Dietary assessment

Dietary intakes were assessed by using the self-administered, semiquantitative 1998 Block (Block 98) FFQ. For each FFQ item, a common serving size of the food or beverage is specified (e.g., 64 g carrots), and participants are asked the frequency of consumption, on average, of this amount during the previous year. Individuals selected from 9 possible frequencies ranging from “never or less than once per month” to “1 (or 2) or more times per day” and selected the appropriate portion size. Portion size for unitary items (e.g., eggs) was queried as “1, 2, or 3” and the number consumed each time reported. For nonunitary foods, a photo was provided to aid in estimating 4 different portions. For each food, an amount was assigned on the basis of the gram weight of the volume for the selected portion-size model. Participants completed the FFQs at home and mailed them to the study center where they were checked for completeness and scanned. Scanned FFQ files were then sent to NutritionQuest (Berkeley, CA) for processing. The amount of each food consumed was calculated by multiplying the reported frequency by the portion size for each food item. We classified the 107 FFQ items into 56 food categories on the basis of culinary use (e.g., high- and low-fat milk) and similarities in nutrient content [e.g., fruit juice-flavored beverages such as Hi-C (Minute Maid, Coca-Cola) and SSBs] (Supplemental Table 1) (28; SE Judd, AJ Letter, JM Shikany, DL Roth, PK Newby, unpublished results, 2012). The Block 98 FFQ has not been validated in the REGARDS study cohort but it has been validated among Canadian women. FFQ reliability was high (Pearson correlation coefficients ranged from 0.57 to 0.9; median = 0.75) and validity was moderate to high (deattenuated Pearson correlation coefficients: 0.11–0.73; median = 0.59) (34).

Women who completed an FFQ (n = 6964), compared with those who did not complete an FFQ (n = 2146), were more likely to be from the Stroke Belt, to be married, to have a college degree and higher annual income (≥$35,000), and to be physically active as well as to be postmenopausal and taking hormone therapy. FFQ completers, relative to FFQ noncompleters, also had lower BMI, a smaller WC, higher prevalence of normal weight and overweight, lower prevalence of total obesity and abdominal obesity, and a better metabolic profile (lower blood pressure; lower mean HOMA-IR index; lower concentrations of insulin, glucose, and hs-CRP; higher concentrations of HDL cholesterol; as well as lower prevalence of hypertension, hypertension treatment, hyperglycemia, insulin resistance, and low HDL cholesterol) (all P < 0.05; data not shown).

Statistical analysis

Race-specific analyses were conducted a priori, given the race differences in dietary intakes (2730; SE Judd, AJ Letter, JM Shikany, DL Roth, PK Newby, unpublished results, 2012).

Characteristics.

ANOVA was used to compare mean differences in continuous variables between white and black women (35). A chi-square test was used to compare differences in proportions of categorical variables in the subgroups of women (35). Participant characteristics included age, energy intake, BMI, WC, blood pressure, glucose, insulin, HOMA-IR, HDL cholesterol, TGs, and hs-CRP in their continuous form. Residential region (Stroke Belt, other), marital status (married, other), educational level (less than college degree, college degree or higher), annual income (<$35,000, ≥$35,000), alcohol intake (none, moderate, heavy) multivitamin use (yes, no), cigarette smoking status (nonsmoker, current smoker), physical activity (0, 1–3, ≥4 times/wk), television viewing (0 h/wk, 1–6 h/wk, ≥1 h/d), BMI categories (normal weight, overweight, obese), elevated WC (yes, no), elevated blood pressure (yes, no), hypertension medication (yes, no), elevated glucose (yes, no), HOMA-IR quartiles (1, 3/4), low HDL cholesterol (yes, no), elevated TGs (yes, no), lipid-lowering medication (yes, no), hormone therapy (yes, no), and postmenopausal status (yes, no) were analyzed as categorical variables. Results were summarized as means ± SEMs for continuous measures and percentages for categorical variables.

Food intake.

ANCOVA was used to compute age-adjusted and multivariable-adjusted least-squares means of food intake (vegetables, fruits, whole-grain bread, refined grains, beans, fish, poultry, red meat, processed meat, fried foods, low-fat dairy, high-fat dairy, 100% fruit juice, SSBs) and to identify pairwise mean differences in the BMI phenotypes (healthy normal weight, abnormal normal weight, healthy overweight, abnormal overweight, healthy obese, abnormal obese) by using Tukey’s honestly significant difference test (which adjusted for multiple comparisons being examined). The SAS procedure PROC GLM was used to fit ANCOVA models (36). Three hierarchical models were fitted: model 1 adjusted for baseline age; model 2 additionally adjusted for BMI, marital status, residential region, educational level, income, alcohol intake, multivitamin use, cigarette smoking status, physical activity, television viewing, hs-CRP, menopausal status, hormone therapy, and food intakes; and model 3 further adjusted for energy intake. Results were summarized as means ± SEMs.

All analyses were performed by using the SAS (version 9.2, 2008) (35). P < 0.05 was considered significant. All statistical tests were 2-sided.

Results

Characteristics.

Compared with black women, white women were older and were more likely to be married, have a college degree and an annual income of ≥$35,000, and live in the Stroke Belt (P < 0.0001). White women were more likely to consume alcohol, use multivitamins, and to exercise but less likely to smoke and watch television than black women (P < 0.01). More white women were also postmenopausal and taking hormone therapy relative to black women (P < 0.05). Mean BMI, WC, systolic and diastolic blood pressure, HOMA-IR, as well as mean concentrations of insulin, glucose, and hs-CRP were lower in white women than in black women as was the prevalence of total obesity, abdominal obesity, hypertension, hypertension treatment, hyperglycemia, and insulin resistance (P < 0.0001). Conversely, the prevalence of normal weight, overweight, lipid-lowering treatment, and hypertriglyceridemia, as well as mean TG concentrations were lower in black women (P < 0.05). White and black women did not differ in energy intake, mean HDL-cholesterol concentration, and prevalence of low HDL cholesterol (Table 1). White women had higher intakes of vegetables, red meat, low-fat dairy, and high-fat dairy as well as lower intakes of fruits, refined grains, processed meat, fried foods, fruit juice, and SSBs than did black women (P < 0.05) (Table 2).

TABLE 1.

Characteristics of women in the REGARDS study1

Characteristic White (n = 4598) Black (n = 2366) P
Sociodemographic
 Age, y 63.9 ± 0.1 62.6 ± 0.2 <0.0001
 Residing in Stroke Belt, % 61.2 52.3 <0.0001
 Married, % 59.1 35.9 <0.0001
 College degree or higher, % 38.3 30.5 <0.0001
 Income ≥$35,000, % 49.5 36.9 <0.0001
Lifestyle
 Energy intake,2 Mcal/d 1.58 ± 0.01 1.6 ± 0.01 0.07
 Alcohol intake, % <0.0001
  None 58.7 74.4
  Moderate (≤14 g/d) 35.6 23.5
  Heavy (>14 g/d) 5.7 2.2
 Multivitamin use, % 34.8 22.5 <0.0001
 Current smokers, % 12.6 15.8 0.0002
 Physical activity, % 0.0019
  0 times/wk 33.9 37.7
  1–3 times/wk 38.1 37.3
  ≥4 times/wk 28.0 25.0
 Television viewing, % 0.0015
  0 h/wk 1.1 0.3
  1–6 h/wk 14.5 13.5
  ≥1 h/d 84.5 86.2
Clinical
 BMI, kg/m2 27.6 ± 0.1 31.2 ± 0.1 <0.0001
 BMI category, % <0.0001
  Normal weight (BMI 18.5 to <25.0) 36.9 16.4
  Overweight (BMI 25 to <30) 35.2 33.3
  Obese (BMI ≥30) 27.9 50.4
 Waist circumference, cm 86.8 ± 0.2 94.1 ± 0.3 <0.0001
 Elevated waist circumference (≥88 cm), % 42.3 64.0 <0.0001
 Systolic blood pressure, mm Hg 122.2 ± 0.2 128.2 ± 0.3 <0.0001
 Diastolic blood pressure, mm Hg 74.4 ± 0.1 78.2 ± 0.2 <0.0001
 Elevated blood pressure (≥130/≥85 mm Hg), % 43.6 68.2 <0.0001
 Hypertension medication, % 37.7 61.9 <0.0001
 Serum glucose,3 mmol/L 5.06 ± 0.01 5.18 ± 0.01 <0.0001
 Elevated serum glucose (≥5.6 mmol/L), % 17.6 26.0 <0.0001
 Serum insulin,4 pmol/L 68.8 ± 0.7 95.1 ± 1.4 <0.0001
 HOMA-IR index 23.0 ± 0.3 32.6 ± 0.6 <0.0001
 Insulin-resistant (HOMA-IR quartile 4), % 40.7 60.5 <0.0001
 Serum HDL cholesterol,5 mmol/L 1.54 ± 0.01 1.52 ± 0.01 0.08
 Low serum HDL cholesterol (<1.3 mmol/L), % 29.7 30.1 0.76
 Serum TGs,6 mmol/L 1.51 ± 0.01 1.14 ± 0.01 <0.0001
 Elevated serum TGs (≥1.7 mmol/L), % 30.4 12.3 <0.0001
 Lipid-lowering medication, % 25.6 23.3 0.0259
 Serum high-sensitivity C-reactive protein,7 mg/L 40.0 ± 1.0 56.0 ± 1.0 <0.0001
 Hormone therapy, % 66.1 49.8 <0.0001
 Postmenopausal, % 89.9 88.3 0.0282
1

Values are means ± SEMs or percentages. Variables are unadjusted. ANOVA was used to compare mean differences in continuous variables between white and black women. Chi-square test was used to compare differences in percentages of categorical variables in the subgroups of women. REGARDS, REasons for Geographic And Racial Differences in Stroke.

2

To convert kcal to kJ, multiply by 4.184.

3

To convert glucose to conventional units, divide by 0.0555.

4

To convert insulin to conventional units, divide by 6.945.

5

To convert cholesterol to conventional units, divide by 0.0259.

6

To convert TGs to conventional units, divide by 0.0113.

7

To convert C-reactive protein to conventional units, divide by 10.

TABLE 2.

Age-adjusted mean food intake of women in the REGARDS study1

Intake, g/d
Food group White (n = 4598) Black (n = 2366) P
Vegetables 213 ± 2 175 ± 3 <0.0001
Fruits 132 ± 2 140 ± 3 0.0327
Whole-grain bread 15.9 ± 0.3 15.7 ± 0.4 0.63
Refined grains 20.1 ± 0.4 24.1 ± 0.6 <0.0001
Beans 12.2 ± 0.3 12.4 ± 0.5 0.72
Fish 18.4 ± 0.4 18.7 ± 0.5 0.60
Poultry 13.7 ± 0.3 13.8 ± 0.4 0.82
Red meat 30.1 ± 0.4 23.2 ± 0.6 <0.0001
Processed meat 12.7 ± 0.3 19.0 ± 0.4 <0.0001
Fried foods 15.4 ± 0.4 32.4 ± 0.6 <0.0001
Low-fat dairy 108 ± 3 27 ± 4 <0.0001
High-fat dairy 98.5 ± 2.3 84.9 ± 3.2 0.0006
100% Fruit juice 105 ± 3 187 ± 4 <0.0001
SSBs 113 ± 4 223 ± 6 <0.0001
1

Values are means ± SEMs. ANCOVA was used to compute age-adjusted least-squares means of food intake and to calculate pairwise mean differences in food intakes between white and black women. REGARDS, REasons for Geographic And Racial Differences in Stroke; SSBs, sugar-sweetened beverages.

MetS-defined healthy obesity: prevalence and food intake.

On the basis of MetS criteria, 45% of white obese women and 55% of black obese women were metabolically healthy (Tables 3 and 4). In age-adjusted analyses, white healthy obese and healthy normal-weight women had similar intakes of SSBs, which were significantly lower than those of abnormal obese women (P < 0.0001). By contrast, healthy and abnormal obese women consumed comparable amounts of red meat and fried foods that were higher than those of healthy normal-weight women (P < 0.0001). Intake of processed meat among healthy obese women was lower than that of their abnormal obese counterparts but higher relative to that of healthy normal-weight women (P < 0.0001). However, findings were attenuated and became nonsignificant in multivariable-adjusted models (P ≥ 0.05) (Table 3). In age-adjusted analyses, black healthy obese and healthy normal weight women consumed lower quantities of SSBs that were similar to those consumed by abnormal obese women (P < 0.001).

TABLE 3.

Adjusted mean food intake of white women in the REGARDS study according to BMI phenotype defined by MetS criteria1

BMI phenotype
Normal-weight
Overweight
Obese
Metabolically healthy Metabolically abnormal Metabolically healthy Metabolically abnormal Metabolically healthy Metabolically abnormal
n (%)2 1587 (93.2) 115 (6.8) 1226 (76.0) 388 (24.0) 577 (45.0) 705 (55.0)
Food group, g/d
 Vegetables
  Model 1 218 ± 4 186 ± 15 216 ± 5 202 ± 9 218 ± 7 205 ± 6
  Model 2 204 ± 10 196 ± 16 208 ± 9 207 ± 11 205 ± 11 193 ± 11
 Fruits
  Model 1 141 ± 3a 99 ± 12c 132 ± 4a,b 119 ± 7b,c 132 ± 6a,b 129 ± 5b
  Model 2 130 ± 8 105 ± 13 122 ± 8 122 ± 9 127 ± 9 134 ± 9
 Whole-grain bread
  Model 1 16.3 ± 0.5 14.6 ± 1.9 15.7 ± 0.6 15.2 ± 1.0 16.6 ± 0.8 15.9 ± 0.8
  Model 2 18.3 ± 1.4 18.3 ± 2.2 17.5 ± 1.3 17.0 ± 1.5 17.8 ± 1.6 17.0 ± 1.6
 Refined grains
  Model 1 19.4 ± 0.7 18.9 ± 2.5 19.3 ± 0.8 18.7 ± 1.4 20.8 ± 1.1 22.7 ± 1.0
  Model 2 24.3 ± 1.7 24.2 ± 2.9 23.9 ± 1.6 23.4 ± 2.0 23.9 ± 2.0 25.6 ± 2.0
 Beans
  Model 1 13.4 ± 0.5a,b 15.6 ± 2.0a 11.1 ± 0.6c 11.1 ± 1.1b,c 11.6 ± 0.9a,b,c 11.7 ± 0.8a,b,c
  Model 2 13.1 ± 1.4 16.2 ± 2.3 11.7 ± 1.3 12.0 ± 1.6 11.8 ± 1.6 12.3 ± 1.6
 Fish
  Model 1 18.3 ± 0.6 14.2 ± 2.1 18.6 ± 0.7 17.2 ± 1.2 18.8 ± 1.0 18.6 ± 0.9
  Model 2 19.6 ± 1.5 19.0 ± 2.5 19.9 ± 1.4 19.8 ± 1.7 20.3 ± 1.7 20.9 ± 1.7
 Poultry
  Model 1 13.4 ± 0.5 8.2 ± 1.7 14.0 ± 0.5 13.8 ± 1.0 13.9 ± 0.8 13.7 ± 0.7
  Model 2 10.3 ± 1.2 7.9 ± 2.0 11.3 ± 1.1 12.6 ± 1.3 12.3 ± 1.4 12.6 ± 1.4
 Red meat
  Model 1 26.3 ± 0.8d 26.0 ± 2.8c,d 30.4 ± 0.9b,c 29.7 ± 1.6b,c 32.9 ± 1.3a,b 35.8 ± 1.1a
  Model 2 30.9 ± 1.9 30.9 ± 3.2 32.5 ± 1.8 31.1 ± 2.2 31.8 ± 2.2 33.4 ± 2.3
 Processed meat
  Model 1 11.1 ± 0.4c 11.1 ± 1.3b,c 12.5 ± 0.4b 13.0 ± 0.7b 13.7 ± 0.6b 15.6 ± 0.5a
  Model 2 13.1 ± 0.9 11.4 ± 1.5 12.5 ± 0.9 12.5 ± 1.1 11.6 ± 1.1 12.5 ± 1.1
 Fried foods
  Model 1 12.2 ± 0.5d 14.8 ± 1.8c,d 15.0 ± 0.5c 16.2 ± 1.0b,c 18.7 ± 0.8a,b 19.3 ± 0.7a
  Model 2 13.0 ± 1.2 13.9 ± 2.0 13.3 ± 1.2 12.9 ± 1.4 14.2 ± 1.4 12.5 ± 1.5
 Low-fat dairy
  Model 1 117 ± 5a 96 ± 19a,b 116 ± 6a 101 ± 11a,b 101 ± 9a,b 84 ± 8b
  Model 2 75 ± 13 72 ± 22 82 ± 13 74 ± 15 74 ± 15 67 ± 16
 High-fat dairy
  Model 1 91 ± 4b 95 ± 15a,b 97 ± 5b 96 ± 9a,b 105 ± 7a,b 116 ± 6a
  Model 2 96 ± 11 83 ± 18 104 ± 10 91 ± 12 108 ± 13 109 ± 13
 100% Fruit juice
  Model 1 109 ± 4 123 ± 13 104 ± 4 106 ± 7 100 ± 6 105 ± 5
  Model 2 97 ± 10 119 ± 16 104 ± 9 106 ± 11 110 ± 11 116 ± 12
 SSBs
  Model 1 91 ± 6b 132 ± 23a,b 103 ± 7b 147 ± 13a 106 ± 10b 154 ± 9a
  Model 2 140 ± 17 147 ± 27 134 ± 16 149 ± 19 113 ± 19 140 ± 19
1

Values are means ± SEMs. ANCOVA was used to compute least-squares means of food intakes and to calculate pairwise mean differences in BMI phenotypes. Labeled means in a row without a common letter differ, P < 0.05. Metabolically healthy normal-weight [BMI (kg/m2) 18.5 to < 25.0 and <3 MetS components]; metabolically healthy overweight (BMI 25 to <30 and <3 MetS components); metabolically healthy obese (BMI ≥30 and <3 MetS components); metabolically abnormal normal-weight (BMI 18.5 to <25.0 and ≥3 MetS components); metabolically abnormal overweight (BMI 25 to <30 and ≥3 MetS components); metabolically abnormal obese (BMI ≥ and ≥3 MetS components). Model 1 adjusted for baseline age. Model 2 adjusted for baseline age, BMI, marital status (married, other), residential region (Stroke Belt, other), education (less than college degree, college degree or higher), annual income (<$35,000, ≥35,000), alcohol intake (none, moderate, heavy), multivitamin use (yes, no), cigarette smoking status (nonsmoker, current smoker), physical activity (0, 1–3, ≥4 times/wk), television viewing (0 h/wk, 1–6 h/wk, ≥1 h/d), high-sensitivity C-reactive protein, menopausal status (yes, no), hormone therapy (yes, no), and food intakes (vegetables, fruits, whole-grain bread, refined grains, beans, fish, poultry, red meat, processed meat, fried foods, low-fat dairy, high-fat dairy, 100% fruit juice, SSBs; each food item was adjusted for all other food intakes). MetS, metabolic syndrome; REGARDS, REasons for Geographic And Racial Differences in Stroke; SSBs, sugar-sweetened beverages.

2

Percentage of each BMI category.

TABLE 4.

Adjusted mean food intake of black women in the REGARDS study according to BMI phenotype defined by MetS criteria1

BMI phenotype
Normal-weight
Overweight
Obese
Metabolically healthy Metabolically abnormal Metabolically healthy Metabolically abnormal Metabolically healthy Metabolically abnormal
n (%)2 346 (89.6) 40 (10.4) 597 (74.8) 201 (25.2) 651 (55.1) 531 (44.9)
Food group, g/d
 Vegetables
  Model 1 180 ± 9 143 ± 26 185 ± 6 166 ± 11 173 ± 6 168 ± 7
  Model 2 166 ± 20 140 ± 29 173 ± 18 162 ± 20 163 ± 18 168 ± 19
 Fruits
  Model 1 138 ± 8 151 ± 26 141 ± 6 130 ± 11 140 ± 6 138 ± 7
  Model 2 119 ± 21 163 ± 31 117 ± 19 118 ± 21 111 ± 19 116 ± 20
 Whole-grain bread
  Model 1 15.2 ± 1.1 12.3 ± 3.5 15.6 ± 0.8 14.7 ± 1.5 15.4 ± 0.8 16.3 ± 0.9
  Model 2 11.2 ± 3.1 9.6 ± 4.6 12.2 ± 2.9 11.1 ± 3.1 12.9 ± 2.9 14.6 ± 2.9
 Refined grains
  Model 1 22.6 ± 2.0 25.3 ± 6.1 25.2 ± 1.5 26.3 ± 2.6 24.3 ± 1.4 23.5 ± 1.6
  Model 2 24.6 ± 5.1 28.9 ± 7.7 24.6 ± 4.8 25.3 ± 5.2 21.7 ± 4.8 20.3 ± 4.9
 Beans
  Model 1 13.6 ± 1.4 9.9 ± 4.4 12.2 ± 1.1 14.8 ± 1.8 12.6 ± 1.0 10.8 ± 1.1
  Model 2 15.2 ± 3.1 15.5 ± 4.6 15.5 ± 2.9 18.5 ± 3.2 16.0 ± 2.9 14.5 ± 3.0
 Fish
  Model 1 17.9 ± 1.6 12.7 ± 5.0 18.7 ± 1.2 17.2 ± 2.1 20.9 ± 1.2 18.3 ± 1.3
  Model 2 19.5 ± 4.1 18.0 ± 6.1 18.5 ± 3.9 17.8 ± 4.2 20.0 ± 3.9 17.6 ± 3.9
 Poultry
  Model 1 12.8 ± 1.2 8.8 ± 3.7 13.5 ± 0.9 13.1 ± 1.5 15.2 ± 0.8 14.7 ± 0.9
  Model 2 11.9 ± 3.0 9.6 ± 4.4 10.8 ± 2.8 11.3 ± 3.0 11.9 ± 2.8 12.1 ± 2.9
 Red meat
  Model 1 19.4 ± 1.6c 19.9 ± 4.9a,b,c 23.0 ± 1.2b,c 21.9 ± 2.0b,c 23.8 ± 1.1b 27.5 ± 1.3a
  Model 2 26.1 ± 4.0 24.1 ± 6.0 27.1 ± 3.7 24.7 ± 4.1 25.5 ± 3.7 27.6 ± 3.8
 Processed meat
  Model 1 15.0 ± 1.2d 17.3 ± 3.6a,b,c,d 17.5 ± 0.9c,d 18.8 ± 1.5b,c 20.5 ± 0.8a,b 22.3 ± 0.9a
  Model 2 19.3 ± 2.8 17.6 ± 4.2 19.3 ± 2.6 19.3 ± 2.9 19.4 ± 2.6 18.9 ± 2.7
 Fried foods
  Model 1 22.8 ± 2.1c 21.7 ± 6.6b,c 31.3 ± 1.6b 33.9 ± 2.8a,b 35.0 ± 1.5a,b 38.4 ± 1.7a
  Model 2 26.4 ± 5.2 27.3 ± 7.7 31.6 ± 4.8 33.1 ± 5.3 31.9 ± 4.8 32.6 ± 4.9
 Low-fat dairy
  Model 1 30.6 ± 5.1 40.5 ± 15.8 25.6 ± 3.8 15.5 ± 6.6 30.8 ± 3.7 19.9 ± 4.1
  Model 2 23.6 ± 13.6 47.2 ± 20.3 17.4 ± 12.7 10.3 ± 13.9 21.9 ± 12.7 12.7 ± 13.0
 High-fat dairy
  Model 1 91 ± 7 101 ± 23 78 ± 6 75 ± 10 88 ± 5 85 ± 6
  Model 2 92 ± 20 108 ± 30 72 ± 19 63 ± 21 78 ± 19 68 ± 19
 100% fruit juice
  Model 1 205 ± 12 182 ± 37 180 ± 9 198 ± 16 182 ± 9 178 ± 10
  Model 2 236 ± 32 193 ± 47 210 ± 30 227 ± 32 203 ± 30 198 ± 30
 SSBs
  Model 1 193 ± 18c 226 ± 55a,b,c 200 ± 13c 257 ± 23a,b 218 ± 13b,c 276 ± 14a
  Model 2 155 ± 46 127 ± 68 169 ± 43 195 ± 47 168 ± 43 206 ± 44
1

Values are means ± SEMs. ANCOVA was used to compute least-squares means of food intakes and to calculate pairwise mean differences in BMI phenotypes. Labeled means in a row without a common letter differ, P < 0.05. Metabolically healthy normal-weight [BMI (kg/m2) 18.5 to < 25.0 and <3 MetS components]; metabolically healthy overweight (BMI 25 to <30 and <3 MetS components); metabolically healthy obese (BMI ≥30 and <3 MetS components); metabolically abnormal normal-weight (BMI 18.5 to <25.0 and ≥3 MetS components); metabolically abnormal overweight (BMI 25 to <30 and ≥3 MetS components); metabolically abnormal obese (BMI ≥ and ≥3 MetS components). Model 1 adjusted for baseline age. Model 2 adjusted for baseline age, BMI, marital status (married, other), residential region (Stroke Belt, other), education (less than college degree, college degree or higher), annual income (<$35,000, ≥35,000), alcohol intake (none, moderate, heavy), multivitamin use (yes, no), cigarette smoking status (nonsmoker, current smoker), physical activity (0, 1–3, ≥4 times/wk), television viewing (0 h/wk, 1–6 h/wk, ≥1 h/d), high-sensitivity C-reactive protein, menopausal status (yes, no), hormone therapy (yes, no), and food intakes (vegetables, fruits, whole-grain bread, refined grains, beans, fish, poultry, red meat, processed meat, fried foods, low-fat dairy, high-fat dairy, 100% fruit juice, SSBs; each food item was adjusted for all other food intakes). MetS, metabolic syndrome; REGARDS, REasons for Geographic And Racial Differences in Stroke; SSBs, sugar-sweetened beverages.

2

Percentage of each BMI category.

Conversely, healthy obese and abnormal obese women had comparable significantly higher intakes of processed meat and fried foods that were higher than those of healthy normal-weight women (P < 0.0001). Red meat consumption among healthy obese women was, however, higher than that of their normal-weight counterparts but lower than that of abnormal obese women (P < 0.05). Results were attenuated and became nonsignificant in multivariable-adjusted analyses (P ≥ 0.05) (Table 4).

HOMA-IR–defined healthy obesity: prevalence and food intake.

The prevalence of healthy obesity when defined by HOMA-IR criteria was lower among both white obese (28%) and black obese (24%) women in comparison to MetS criteria. Furthermore, prevalence was lower among black women than in white women in contrast to the MetS criteria. Similar to results with MetS criteria, relations between food intakes and BMI phenotypes were evident in age-adjusted analyses only (Supplemental Tables 2 and 3).

White healthy obese and healthy normal-weight women had similar significantly higher intakes of fruits and low-fat dairy products than those of abnormal obese women (P < 0.001); they also had comparable intakes of SSBs, which were lower than those of abnormal obese women (P < 0.0001). However, obese phenotypes were associated with higher consumption of processed meat than that of healthy normal-weight women (P < 0.0001). Intakes of red meat and fried foods among healthy obese women were lower than those of their obese counterparts but higher than those of healthy normal-weight women (P < 0.0001). Findings were attenuated and became nonsignificant in multivariable-adjusted models (P ≥ 0.05) (Supplemental Table 2).

Black healthy obese and healthy normal-weight women consumed comparable lower amounts of SSBs than did abnormal obese women (P < 0.001). By contrast, healthy and abnormal obese women had similar intakes of processed meat and fried foods that were significantly higher than those of healthy normal-weight women (P < 0.0001). Results were attenuated and became nonsignificant in multivariable-adjusted analyses (P ≥ 0.05) (Supplemental Table 3).

Among both white and black women, no relations were observed between the other phenotypes and food intakes. Multivariable-adjusted models with and without energy adjustment were similar in both sets of analyses (data not shown).

Discussion

Healthy obesity was prevalent among REGARDS study women and varied by definition, being higher with MetS criteria (white: 45%; black: 55%) than with HOMA-IR criteria (white: 28%; black: 24%). Although food intakes were associated with healthy obesity and other BMI phenotypes in simple models, results were attenuated and no longer significant in models adjusted for potential confounders.

There are no published data on the prevalence of white healthy obese women in the United States. The prevalence of the phenotype in black women on the basis of absence of MetS in the Howard University Family Study (28%) (37) and on HOMA-IR in Ohio (33%) (38) was higher than that for black women in our study. Globally, reported prevalences of MetS-defined healthy obesity in women (23–42%) (9, 14, 15, 39) are lower relative to those for the women in the REGARDS study. Conversely, the prevalence of the HOMA-IR–defined phenotype was comparatively higher (43%) in the CoLaus (Cohorte Lausannoise) Study (39).

Consistent with findings in REGARDS study women, food intakes of healthy and unhealthy obese INTERMAP study adults did not differ (20). However, our study is unique in comparing food consumption across BMI phenotypes of white and black women defined by using more than one criteria. The higher prevalence of MetS-based healthy obesity compared with that defined by HOMA-IR among black women might be attributable to the fact that lipid measures are not predictive of insulin resistance in blacks (characterized by normal TGs and low HDL cholesterol), which results in underdiagnosis of MetS (40). Likewise, the variable prevalences among studies may be due to the age of participants as well as the use of different protocols for insulin sensitivity and varying cutoffs for obesity and MetS components (7).

The lack of association between diet and BMI phenotypes may underscore inadequacies of single-food analysis that fail to consider interactions and cumulative effects of foods and nutrients as well as biological interactions of diet with other metabolic factors (40, 41). Nevertheless, we chose to begin our assessment of dietary intakes among BMI phenotypes of REGARDS study women with food intakes before proceeding to the dietary pattern level in future research. The dietary pattern approach, which considers total diet and related interactions, complements single-food analysis (27, 41, 42) and may better inform the relation between diet and healthy obesity. For instance, the relations of SSBs (4347) and high-fat foods, including high-fat dairy (4850) and meat (51), with obesity remain controversial and evidence is inconclusive. Some studies demonstrate an effect of SSBs on body weight, although the effect size is small and of equivocal significance. In a comprehensive review of the relation between high-fat dairy foods and obesity (50), high-fat dairy, consumed within distinctive dietary patterns, was found to protect against obesity. Bioactive substances in dairy fat (FAs such as butyric acid, phytanic acid, cis- and trans-palmitoleic acid) as well as pasture/grass-based dairy cow feeds (vs. grain/concentrate-based fodder) are hypothesized to confer health benefits. The only review (51) on meat intake and obesity demonstrated a positive association with both red and processed meat consumption; however, the heterogeneity among studies precludes a definitive conclusion being drawn. Moreover, there is insufficient evidence regarding the effect of SFAs and MUFAs, the main components of dairy and meat fat, on body weight (5255). The proposition is that the weight gain associated with SSBs and high-fat foods that is observed is some studies is attributable to increased overall energy intake rather than to SSBs and high-fat foods (47, 48, 53, 56). Likewise, evidence suggests that lifestyle factors, including unhealthy diet, immoderate alcohol and tobacco use, physical inactivity, and sedentary behavior, tend to cluster, making it challenging to tease out the effect of a single component (43, 57).

Strengths of our study include a large, well-characterized, national, and diverse population as well as comparisons of food consumption with the use of 2 definitions of healthy obesity. The study comprised women of a broad age range with a large representation of black women and regional data. In contrast to other studies, associations of race and diet with healthy obesity were examined and analyses were also adjusted for a broad range of covariates.

A limitation of the study is its cross-sectional design, which has known limitations. Nonetheless, our objective was to evaluate the interrelations of BMI phenotypes and race on food intakes before performing prospective studies. The Block 98 FFQ is somewhat old but is ideal for the REGARDS study cohort because it specifically comprised foods contributing to diets of U.S. blacks (28, 30) and was among the main tools used to collect dietary data on racially diverse populations around the time the study was initiated (2003). However, it is likely the FFQ did not adequately discriminate between dietary intakes among white and black adults, potentially misclassifying and attenuating true differences in dietary intakes. Tucker et al. (58) developed a regional FFQ for use among Southern black populations, which contains more culturally specific foods and may have been a more suitable instrument, but the FFQ was not available at the inception of the REGARDS study. Furthermore, dietary self-report errors may have influenced our findings (59). The majority of women who completed an FFQ (58%) were from the Stroke Belt, possibly because individuals from this region were oversampled. In addition, FFQ completers were more likely to be married, to have a higher educational level and socioeconomic status, to be postmenopausal and taking hormone therapy, as well as to have a healthier lifestyle and better metabolic and health profiles. Educated people and those with higher socioeconomic status tend to be healthy and to participate more in studies, indicating greater awareness and trust in science. They are similarly apt to have healthy lifestyles, as are older and married individuals (6062). Our study sample might thus constitute a somewhat healthier subgroup and hence limit the generalizability of our results. Finally, HOMA-IR results require cautious interpretation given the lack of standardization of insulin measures (63).

In conclusion, approximately one-half of obese women in the REGARDS study as defined by MetS criteria and approximately one-quarter defined on the basis of HOMA-IR were metabolically healthy. Food intakes were not associated with healthy obesity or with other BMI phenotypes. Prospective studies on relations of dietary patterns, which may be a better indicator of usual diet, with healthy obesity would be beneficial.

Supplementary Material

Online Supporting Material

Acknowledgments

We thank the other investigators (George Howard, Virginia Howard, Leslie McClure, David Rhodes, Monika Safford, and Virginia Wadley of the University of Alabama at Birmingham; Elaine Cornell, Mary Cushman, Nancy Jenny, and Neil Zakai of the University of Vermont; Elsayed Z. Soliman of Wake Forest University; LeaVonne Pulley of the University of Arkansas for Medical Sciences; Brett Kissela and Dawn Kleindorfer of the University of Cincinnati; Daniel Lackland of Medical University of South Carolina; Frederick Unverzagt of Indiana University School of Medicine; and Claudia Moy of the National Institute of Neurological Disorders and Stroke, NIH), and the staff (Andra Graham and Kathy Gainer). A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org.

We thank Alison Eldridge, previously at the General Mills Bell Institute of Health and Nutrition, for generously providing the funding to analyze the dietary data collected from REGARDS participants. We also thank Satya Jonnalagadda, Principal Scientist at the General Mills Bell Institute of Health and Nutrition, for her continued support of this project and her patience. Neither Dr. Eldridge nor Dr. Jonnalagadda was involved in the analysis or writing of this manuscript in any way. Torin Block, at NutritionQuest, was especially helpful in providing input on the Block 98 FFQ and nutrient analyses. RWK designed the research and wrote the manuscript; SEJ conducted the statistical analysis; JMS provided significant advice and consultation; and PKN contributed to the study design and writing of the manuscript. All of the authors had primary responsibility for final content and read and approved the final manuscript.

Footnotes

10

Abbreviations used: CVD, cardiovascular disease; hs-CRP, high-sensitivity C-reactive protein; MetS, metabolic syndrome; REGARDS, REasons for Geographic And Racial Differences in Stroke; SSB, sugar-sweetened beverage; WC, waist circumference.

References

  • 1.Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 2014;129:399–410. [DOI] [PubMed] [Google Scholar]
  • 3.World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington: AICR; 2007 [cited 2013 Jan 9]. Available from: http://www.dietandcancerreport.org/.
  • 4.Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014;129(25 Suppl 2)S102–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011;35:971–81. [DOI] [PubMed] [Google Scholar]
  • 7.Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013;14:219–27. [DOI] [PubMed] [Google Scholar]
  • 8.Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906–12. [DOI] [PubMed] [Google Scholar]
  • 9.Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109:706–13. [DOI] [PubMed] [Google Scholar]
  • 10.Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 2012;20:651–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013;34:389–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Durward CM, Hartman TJ, Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes 2012;2012:460321. [DOI] [PMC free article] [PubMed]
  • 13.Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008;168:1617–24. [DOI] [PubMed] [Google Scholar]
  • 14.Hwang LC, Bai CH, Sun CA, Chen CJ. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012;21:227–33. [PubMed] [Google Scholar]
  • 15.Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome? BMC Public Health 2011;11:383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5. [DOI] [PubMed] [Google Scholar]
  • 17.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9. [DOI] [PubMed] [Google Scholar]
  • 18.Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442–3. [DOI] [PubMed] [Google Scholar]
  • 19.Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 2014;311:806–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hankinson AL, Daviglus ML, Van Horn L, Chan Q, Brown I, Holmes E, Elliott P, Stamler J. Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 2013;21:637–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr 2009;18:280–4. [PubMed] [Google Scholar]
  • 22.Manu P, Ionescu-Tirgoviste C, Tsang J, Napolitano BA, Lesser ML, Correll CU. Dysmetabolic signals in "metabolically healthy" obesity. Obes Res Clin Pract 2012;6:e9–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wizemann TM, Pardue ML. editors. Committee on Understanding the Biology of Sex and Gender Differences, Board on Health Sciences Policy, Institute of Medicine. Exploring the biological contributions to human health: does sex matter? Washington: National Academies Press; 2001[cited 2013 Jan 9]. Available from: http://www.nap.edu/catalog/10028.html. [PubMed]
  • 24.Lovejoy JC, Sainsbury A; Stock Conference 2008 Working Group. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev 2009;10:154–67. [DOI] [PubMed] [Google Scholar]
  • 25.Kimokoti RW, Newby PK, Gona P, Zhu L, McKeon-O'Malley C, Pablo Guzman J, D'Agostino RB, Millen BE. Patterns of weight change and progression to overweight and obesity differ in men and women: implications for research and interventions. Public Health Nutr 2013;16:1463–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Magkos F, Wang X, Mittendorfer B. Metabolic actions of insulin in men and women. Nutrition 2010;26:686–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Newby PK, Tucker KL. Empirically derived eating patterns using factor or cluster analysis: a review. Nutr Rev 2004;62:177–203. [DOI] [PubMed] [Google Scholar]
  • 28.Newby PK, Noel SE, Grant R, Judd S, Shikany JM, Ard J. Race and region have independent and synergistic effects on dietary intakes in black and white women. Nutr J 2012;11:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nahab F, Le A, Judd S, Frankel MR, Ard J, Newby PK, Howard VJ. Racial and geographic differences in fish consumption: the REGARDS study. Neurology 2011;76:154–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Newby PK, Noel SE, Grant R, Judd S, Shikany JM, Ard J. Race and region are associated with nutrient intakes among black and white men in the United States. J Nutr 2011;141:296–303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The REasons for Geographic and RAcial Differences in Stroke study: objectives and design. Neuroepidemiology 2005;25:135–43. [DOI] [PubMed] [Google Scholar]
  • 32.Levine DA, Calhoun DA, Prineas RJ, Cushman M, Howard VJ, Howard G. Moderate waist circumference and hypertension prevalence: the REGARDS study. Am J Hypertens 2011;24:482–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lakoski SG, Le AH, Muntner P, Judd SE, Safford MM, Levine DA, Howard G, Cushman M. Adiposity, inflammation, and risk for death in black and white men and women in the United States: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Clin Endocrinol Metab 2011;96:1805–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 2006;9:84–93. [DOI] [PubMed] [Google Scholar]
  • 35.Lomax RG. An introduction to statistical concepts. Mahwah (NJ): Lawrence Erlbaum Associates; 2007. [Google Scholar]
  • 36. SAS Institute. Statistical Applications Software. Version 9.1. Cary (NC): SAS Institute; 2004.
  • 37.Doumatey AP, Bentley AR, Zhou J, Huang H, Adeyemo A, Rotimi CN. Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in African Americans. J Endocrinol Metab. 2012;2:51–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Gaillard TR, Schuster D, Osei K. Characterization of metabolically unhealthy overweight/obese African American women: significance of insulin-sensitive and insulin-resistant phenotypes. J Natl Med Assoc 2012;104:164–71. [DOI] [PubMed] [Google Scholar]
  • 39.Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010;64:1043–51. [DOI] [PubMed] [Google Scholar]
  • 40.Yu SS, Castillo DC, Courville AB, Sumner AE. The triglyceride paradox in people of African descent. Metab Syndr Relat Disord 2012;10:77–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Moeller SM, Reedy J, Millen AE, Dixon LB, Newby PK, Tucker KL, Krebs-Smith SM, Guenther PM. Dietary patterns: challenges and opportunities in dietary patterns research: an Experimental Biology workshop, April 1, 2006. J Am Diet Assoc 2007;107:1233–9. [DOI] [PubMed] [Google Scholar]
  • 42.Jacobs DR, Jr, Tapsell LC. Food, not nutrients, is the fundamental unit in nutrition. Nutr Rev 2007;65:439–50. [DOI] [PubMed] [Google Scholar]
  • 43.Malik VS, Popkin BM, Bray GA, Després JP, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010;121:1356–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hu FB. Resolved: there is sufficient scientific evidence that decreasing sugar-sweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases. Obes Rev 2013;14:606–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kaiser KA, Shikany JM, Keating KD, Allison DB. Will reducing sugar-sweetened beverage consumption reduce obesity? Evidence supporting conjecture is strong, but evidence when testing effect is weak. Obes Rev 2013;14:620–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? Health be damned! Pour on the sugar. Diabetes Care 2014;37:950–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kahn R, Sievenpiper JL. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? We have, but the pox on sugar is overwrought and overworked. Diabetes Care 2014;37:957–62. [DOI] [PubMed] [Google Scholar]
  • 48.Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;96:735–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Louie JC, Flood VM, Hector DJ, Rangan AM, Gill TP. Dairy consumption and overweight and obesity: a systematic review of prospective cohort studies. Obes Rev 2011;12:e582–92. [DOI] [PubMed] [Google Scholar]
  • 50.Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 2013;52:1–24. [DOI] [PubMed] [Google Scholar]
  • 51.Rouhani MH, Salehi-Abargouei A, Surkan PJ, Azadbakht L. Is there a relationship between red or processed meat intake and obesity? A systematic review and meta-analysis of observational studies. Obes Rev 2014;15:740–8. [DOI] [PubMed] [Google Scholar]
  • 52.Månsson HL. Fatty acids in bovine milk fat. Food Nutr Res 2008;52. [DOI] [PMC free article] [PubMed]
  • 53.Schmid A. The role of meat fat in the human diet. Crit Rev Food Sci Nutr 2011;51:50–66. [DOI] [PubMed] [Google Scholar]
  • 54.Melanson EL, Astrup A, Donahoo WT. The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome. Ann Nutr Metab 2009;55:229–43. [DOI] [PubMed] [Google Scholar]
  • 55.Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010;45:893–905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Obesity Society. Reduced consumption of sugar-sweetened beverages can reduce total caloric intake [cited 2013 May 16]. Available from: http://www.obesity.org/publications/position-statements.htm.
  • 57.Kimokoti RW, Newby PK. Dietary patterns, smoking, and cardiovascular diseases: a complex association. Curr Nutr Rep. 2013;2:113–25. [Google Scholar]
  • 58.Tucker KL, Maras J, Champagne C, Connell C, Goolsby S, Weber J, Zaghloul S, Carithers T, Bogle ML. A regional food-frequency questionnaire for the US Mississippi Delta. Public Health Nutr 2005;8:87–96. [PubMed] [Google Scholar]
  • 59.Willett W. Nutritional epidemiology. 3rd ed. New York: Oxford University Press; 2012. [Google Scholar]
  • 60.Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol 2007;17:643–53. [DOI] [PubMed] [Google Scholar]
  • 61.Tolonen H, Dobson A, Kulathinal S; WHO MONICA Project. Effect on trend estimates of the difference between survey respondents and non-respondents: results from 27 populations in the WHO MONICA Project. Eur J Epidemiol 2005;20:887–98. [DOI] [PubMed] [Google Scholar]
  • 62.Waite LJ, Lehrer EL. The benefits from marriage and religion in the United States: a comparative analysis. Popul Dev Rev 2003;29:255–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, Caudill SP, Campbell SE, Steffes MW; Insulin Standardization Workgroup. Standardization of insulin immunoassays: report of the American Diabetes Association workgroup. Clin Chem 2007;53:711–6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Online Supporting Material

Articles from The Journal of Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES